Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > OH MY. IT DOESN'T LOOK GOOD.

<< Previous

Bullboard Posts

Next >>

Comment by Chritterson Aug 26, 2021 12:28pm

138 Views

Post# 33767463

RE:RE:RE:RE:OH MY. IT DOESN'T LOOK GOOD.

Sorry that I hurt your feelings but I hate Bull Sh--ters more then Bashers!! I dont anyone on Stockhouse bashing this stock really effects the Share Count but lack of Communication from the company does!! Maybe you should open your eyes!!

Amazigh wrote:
Chritters, your lack of knowledge and just general idiocracy is appalling. Never met a guy like you, LOL. You do understand that you're helping shills like Losinghisshirt and other shills and bashers. You have shares in this company, but keep defecating where you eat. Incredible!!!